Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Why Catalyst Pharmaceuticals Shares Are Popping Off

Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) shares are trading higher by 6.40% to $16.12 Tuesday after it was announced the company will join the S&P SmallCap 600.
byHenry Khederian
September 13, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) shares are trading higher by 6.40% to $16.12 Tuesday after it was announced the company will join the S&P SmallCap 600.

Catalyst Pharmaceuticals will replace Mantech International Corp. (NASDAQ:MANT) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, September 15.

The Carlyle Group Inc. (NASD: CG) is acquiring ManTech International in a transaction expected to be completed soon pending final conditions.

See Also: Here’s How Much You’d Have Right Now If You Invested $1,000 In Apple Shares When Steve Jobs Resigned As CEO In 2011

According to data from Benzinga Pro, Catalyst Pharmaceuticals has a 52-week high of $17.22 and a 52-week low of $4.81.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Volatility In Markets Decreases Ahead Of Apple, Amazon Earnings

By Lisa Levin
October 27, 2:18 AM
U.S. stocks closed mostly lower on Wednesday, with the S&P 500 ending a three-session winning streak. US new home sales fell to a 603,000 annual rate in September compared to a revised 677,000 a month ago, while trade gap on goods increased to a three-month high of $92.2 billion in September from a $87.3 billion deficit in the previous month.

AAPL